17 stocks with target price increases exceeding 30%, Hengrui Medicine and Kingsoft Office up over 65% | Brokerage Rating Watch

Questioning AI · Yuyuan Group’s rating downgrade: what potential risks should the market be alert to?

Yuesheng Investment Research data shows that on March 26, securities firms issued target prices for a total of 49 listed companies. Based on the latest closing prices, the companies with the highest target price increases are Hengrui Medicine, Kingsoft Office, and Shanghai Jahwa, with target price increases of 72.69%, 66.67%, and 61.37%, respectively, belonging to the chemical pharmaceuticals, software development, and cosmetics industries.

In terms of the number of securities firm recommendations, on March 26, 70 listed companies received recommendations from securities firms. Among them, China Life received 6 recommendations, Yunnan Rural Commercial Bank received 5, and Anhui Conch Cement received 4.

Regarding rating downgrades, on March 26, Huatai Securities downgraded Yuyuan Group from “Buy” to “Accumulate.”

For initial coverage, on March 26, securities firms provided a total of 11 first-time coverage reports. Among them, Tianshan Railway received a “Hold” rating from Tianfeng Securities, Northeast Securities received a “Recommend” rating from Huachuang Securities, Linuo Pharmaceutical Packaging received a “Hold” rating from Guotai Huitong Securities, Lechuang Technology received a “Hold” rating from Huayuan Securities, and Dongfang Electric received a “Buy” rating from Changjiang Securities.

Disclaimer: The viewpoints, data, and individual stock elements involved in this article are organized by Qin Jian (Registration Number A0590622100001) from Yuesheng Investment Research Data Analyst Team. They are for reference only and do not constitute investment advice. Investment involves risks; operate cautiously when entering the market.